Abstract
Nivolumab is effective in the treatment of classical Hodgkin lymphoma that relapsed after allogeneic hematopoietic stem cell transplantation (SCT) wit......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
